These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5873693)

  • 1. Immunity development in mice RECEIVING KILLED Coccidioides immitis spherules: effect of removing residual vaccine.
    Levine HB; Kong YM
    Sabouraudia; 1965 Oct; 4(3):164-70. PubMed ID: 5873693
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
    Scalarone GM; Levine HB
    Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
    [No Abstract]   [Full Text] [Related]  

  • 3. Deficient resistance to Coccidioides immitis following intravenous vaccination. II. Evidence against an immune tolerance mechanism.
    Scalarone GM; Levine HB
    Sabouraudia; 1971 Jul; 9(2):90-6. PubMed ID: 4939207
    [No Abstract]   [Full Text] [Related]  

  • 4. Attributes of deficient immunity in mice receiving Coccidioides immitis Spherule vaccine by the intravenous route.
    Scalarone GM; Levine HB
    Sabouraudia; 1969 Oct; 7(3):169-77. PubMed ID: 5385153
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
    Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
    Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient resistance to Coccidioides immitis following intravenous vaccination. 3. Humoral and cellular responses to intravenous and intramuscular doses.
    Levine HB; Scalarone GM
    Sabouraudia; 1971 Jul; 9(2):97-108. PubMed ID: 5111563
    [No Abstract]   [Full Text] [Related]  

  • 7. IMMUNIZATION OF MICE TO COCCIDIOIDES IMMITIS: DOSE, REGIMEN AND SPHERULATION STAGE OF KILLED SPHERULE VACCINES.
    LEVINE HB; KONG YC; SMITH C
    J Immunol; 1965 Jan; 94():132-42. PubMed ID: 14253511
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
    Pappagianis D
    Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic impairment in mice treated intravenously with killed Coccidioides immitis spherules: suppressed response to intramuscular doses.
    Levine HB; Kong YC
    J Immunol; 1966 Sep; 97(3):297-305. PubMed ID: 5925701
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis.
    Kirkland TN; Thomas PW; Finley F; Cole GT
    Infect Immun; 1998 Feb; 66(2):424-31. PubMed ID: 9453590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
    Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
    Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
    Walch HA; Kalvoda A
    Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
    Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
    Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of mice against coccidioidomycosis with a subcellular vaccine.
    Pappagianis D; Hector R; Levine HB; Collins MS
    Infect Immun; 1979 Jul; 25(1):440-5. PubMed ID: 478645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.
    Lecara G; Cox RA; Simpson RB
    Infect Immun; 1983 Jan; 39(1):473-5. PubMed ID: 6822433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of vaccinated mice to typical and atypical strains of Coccidioides immitis.
    Huppert M; Levine HB; Sun SH; Peterson ET
    J Bacteriol; 1967 Oct; 94(4):924-7. PubMed ID: 6051364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
    Jiang C; Magee DM; Quitugua TN; Cox RA
    Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
    Fierer J; Waters C; Walls L
    J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.